Novo Integrated Sciences, Inc. Announces Medical Advisory Board Appointments
April 22, 2021 at 08:00 am EDT
Share
Novo Integrated Sciences, Inc. welcomes Dr. Joseph M. Chalil, Dr. Michael G. Muhonen, and Dr. Zach P. Zachariah as charter members to the Company’s newly-formed Medical Advisory Board. This group of world-renowned leaders within their respective medical fields provides the Company with important insight and expertise as the Company expands its personalized consumer engagement across all aspects of the patient/practitioner relationship through the integration of medical technology, advanced therapeutics, and rehabilitative sciences. Dr. Joseph M. Chalil, MD, MBA, FACHE, Chairman of the Medical Advisory Board:Prof. Joseph M. Chalil is an author of several scientific and research papers in international publications, is the Chairman of the Complex Health Systems Advisory Board, H. Wayne Huizenga College of Business and Entrepreneurship at Nova Southeastern University in Florida, and a member of Dr. Kiran C. Patel College of Allopathic Medicine (NSU MD) Executive Leadership Council. A veteran of the U.S. Navy Medical Corps, he is board certified in healthcare management. He has been awarded a Fellowship by the American College of Healthcare Executives, an international professional society of more than 40,000 healthcare executives who lead hospitals, healthcare systems, and other healthcare organizations. Additionally, Dr. Chalil is the Chairman of the Indo-American Press Club (IAPC). He is an expert in U.S. healthcare policy and a strong advocate for patient-centered care. Dr. Michael G. Muhonen, MD: Dr. Muhonen is a renowned neurosurgeon who practices at Children’s Hospital of Orange County. Dr. Muhonen believes in treating all patients like family members and strives to leave every medical situation better than how he encountered it. Dr. Muhonen has been recognized as one of the “Best Doctors in Orange County, California, specialty of Neurological Surgery” in Orange Coast Magazine. Dr. Muhonen has maintained a committed interest in the science of neurological disorders. He is an Associate Clinical Professor at the University of California Irvine, College of Medicine, with ongoing research in hydrocephalus, cerebral palsy, and cerebral blood flow. Dr. Muhonen is board-certified by the American Board of Neurological Surgeons, the American Board of Pediatric Neurological Surgery, and is a Fellow of the American Academy of Pediatrics. He currently oversees a hydrocephalus research lab and has led multiple clinical trials at Children’s Hospital of Orange County. Dr. Muhonen serves on the Board of the Hydrocephalus Association, and previously served on the Boards of the Hydrocephalus Foundation, and the Children’s Hospital of Orange County Foundation. He has been a medical advisor to Medtronic, Alcyone, Anuncia, Codman and Integra LifeSciences. Dr. Zach P. Zachariah, MD: Dr. Zach Zachariah is the Medical Director of UHealth Cardiology, Fort Lauderdale and on the Clinical Faculty of the University of Miami School of Medicine. He is also the President of Fort Lauderdale Heart Institute in Fort Lauderdale, Florida. He has been practicing interventional cardiology at Holy Cross Hospital since 1976 and was its Director of Cardiovascular Services until 2010. Dr. Zachariah is board-certified in internal medicine and cardiology and specializes in cardiology, cardiac catheterization, and interventional cardiology and has performed more than 30,000 heart catheterizations and interventional procedures in Broward County, Florida. He has also co-authored several scientific papers in National Journal and participated in various clinical trials. Currently, he serves as the Chairman of the FloridaBoard of Medicine, and as a member of the National Advisory Council of the National Heart, Lung and Blood Institute of the National Institutes of Health. He also serves as a member of the Board of Trustees of Nova Southeastern University, a member of its executive committee and as the Chairman of the Research and Technology Transfer Committee. He also serves as a member of the Council of 100 in Florida and as a Board member of the National Board of ExcelinED in Action. He also serves as a board member of Geo Toll Inc. He currently serves on the Scientific Advisory Committee of BioSig Technologies, Inc.
Novo Integrated Sciences, Inc. is a parent company to its subsidiaries. The Company owns Canadian and United States subsidiaries that provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The Company operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. Its subsidiaries include Novo Healthnet Limited, Novomerica Health Group, Inc., PRO-DIP, LLC and others.